NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDS: ANTIVIRALS, HIV

抗肿瘤化合物的新合成方法：抗病毒药物、HIV

• 批准号: 7601801
• 负责人: BARRY M TROST
• 金额: $ 19.36万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-30 至 2008-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7601801
• 关键词: Alkaloids; Antiviral Agents; Class; Computer Retrieval of Information on Scientific Projects Database; Development; Funding; Grant; Institution; Research; Research Personnel; Resources; Source; Terpenes; United States National Institutes of Health; analog; novel; programs

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The program involves the development of synthetic strategies to compounds of known antitumor activity to generate structurally related but inaccessible analogues. Compounds of many different classes, including alkaloids, terpenoids, and polyacetates are being examined.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目和 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 该计划涉及开发已知抗肿瘤活性化合物的合成策略，以生成结构相关但难以获得的类似物。 正在检查许多不同类别的化合物，包括生物碱、萜类化合物和聚乙酸酯。